Screener
Aurinia Pharmaceuticals AUPH Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Aurinia Pharmaceuticals’s reported figures.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's invested capital?
- Aurinia Pharmaceuticals (AUPH) reported invested capital of $515.65M in Q2 2026.
- How has Aurinia Pharmaceuticals's invested capital changed year-over-year?
- Aurinia Pharmaceuticals's invested capital increased by 35.6% year-over-year, from $380.3M to $515.65M.
- What is the long-term trend for Aurinia Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's invested capital has grown at a 32.7% compound annual growth rate (CAGR), from $143.81M to $592.45M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Aurinia Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude